Life science and analytical device company Trajan Scientific and Medical will list on the ASX today.
Trajan was established in 2011 by husband-and-wife team Stephen and Angela Tomisich, who began by acquiring a pathology industry consumables business. It has made six acquisitions since, and develops and manufactures devices and solutions, mainly for the medical sector.
The company is headquartered at Ringwood, Melbourne, and employs around 450 globally.
The bell will ring at 10.30 am AEDT and trading of the company’s shares will begin.
“To our new investors: thank you for your support and commitment to Trajan chapter II,” Tomisich said on Linkedin.
“To the world: watch out for what comes next! When you have a team driven and aligned by a purpose to deliver a positive global impact to human well-being anything is possible.”
According to The Australian Financial Review, Trajan filed to list on the exchange, with a market capitalisation of $220 million, last month. It expects revenues of $75 million this financial year.
It raised $90 million at an issue price of $1.20 per share.
Subscribe to our free @AuManufacturing newsletter here.